SCHEMBL21716848

SCHEMBL21716848

c1ccc2cc3c(cc2c1)c1cc(-n2c4ccccc4c4c5ccccc5ccc42)ccc1n3-c1nc(-c2ccc3c4ccccc4c4ccccc4c3c2)nc2ccccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 5/20 0.33
CYP2D6 P10635 5/20 0.33
ABCG2 Q9UNQ0 3/20 0.33
TP53 P04637 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
SIRT1 Q96EB6 1/20 0.33
ALOX15 P16050 1/20 0.33
ROCK2 O75116 2/20 0.33
PTGES O14684 1/20 0.33
GBA1 P04062 1/20 0.33
MAPT P10636 1/20 0.33
ROCK1 Q13464 1/20 0.33
PKN1 Q16512 1/20 0.33
PKN2 Q16513 1/20 0.33
ACP1 P24666 2/20 0.32
USP2 O75604 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716532 0.94 AURKA (0.37) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21716530 0.92 ABCG2 (0.39) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21716834 0.92 ABCG2 (0.40) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21717308 0.92 ROCK2 (0.38) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21717452 0.92 ROCK2 (0.38) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21716347 0.91 ROCK2 (0.34) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21717695 0.91 ABCG2 (0.34) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21213160 0.90 ABCG2 (0.37) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21717174 0.89 ABCG2 (0.36) CYP1A2CYP3A4CYP2D6ABCG2TP53
SCHEMBL21213701 0.89 ABCG2 (0.37) CYP1A2CYP3A4CYP2D6ABCG2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 CYP1A2 6/4885CYP3A4 10/4885CYP2D6 85/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 CYP1A2 6/4885CYP3A4 10/4885CYP2D6 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.